Published in Cancers (Basel) on April 09, 2015
miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation. Oncotarget (2016) 0.88
MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia. Sci Rep (2015) 0.88
MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation. J Clin Med (2015) 0.86
Considering Exosomal miR-21 as a Biomarker for Cancer. J Clin Med (2016) 0.85
MicroRNA aberrations: An emerging field for gallbladder cancer management. World J Gastroenterol (2016) 0.81
Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets. J Clin Med (2015) 0.77
Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation. Am J Cancer Res (2016) 0.77
MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway. PLoS One (2016) 0.76
Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women. Oncotarget (2016) 0.75
MicroRNA Polymorphisms in Cancer: A Literature Analysis. Cancers (Basel) (2015) 0.75
Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study. Oncotarget (2016) 0.75
MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice. Breast Cancer Res (2016) 0.75
Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer. Open Med (Wars) (2016) 0.75
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes. J Hum Genet (2016) 0.75
Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. Am J Transl Res (2017) 0.75
MicroRNAs: Potential Biomarkers and Therapeutic Targets for Alveolar Bone Loss in Periodontal Disease. Int J Mol Sci (2016) 0.75
A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells. Mol Cell Biol (2016) 0.75
MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells. Oncol Lett (2017) 0.75
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis. Br J Cancer (2017) 0.75
Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A. Oncol Lett (2017) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
Cancer metastasis: building a framework. Cell (2006) 19.67
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
Nuclear export of microRNA precursors. Science (2003) 16.59
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell (2007) 13.69
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71
Retracted A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell (2009) 10.51
Intronic microRNA precursors that bypass Drosha processing. Nature (2007) 9.65
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell (2009) 8.33
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta (1976) 7.41
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol (2006) 7.11
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol (2007) 6.41
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J (2007) 6.26
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun (2011) 5.95
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A (2011) 5.53
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med (2012) 5.46
A MicroRNA targeting dicer for metastasis control. Cell (2010) 4.81
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem (2008) 4.56
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell (2014) 4.53
Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell (2012) 4.29
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (1983) 3.88
CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest (2010) 3.60
GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell (2008) 3.44
ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer (2010) 3.44
MicroRNA 29b functions in acute myeloid leukemia. Blood (2009) 3.19
MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell (2013) 2.92
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther (2009) 2.92
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther (2008) 2.85
Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes (2009) 2.78
A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell (2013) 2.68
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature (2013) 2.67
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer (2011) 2.56
Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res (2011) 2.31
E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci (2013) 2.23
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol (2011) 2.19
Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol (2014) 2.15
MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol (2014) 2.13
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol (2013) 2.03
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene (2009) 2.01
The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal (2012) 1.81
GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol (2010) 1.80
Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochem Biophys Res Commun (2003) 1.77
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol (2009) 1.75
ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell (2013) 1.57
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A (2013) 1.54
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res (1983) 1.53
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A (2013) 1.44
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun (2013) 1.43
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res (2012) 1.39
RPN2 gene confers docetaxel resistance in breast cancer. Nat Med (2008) 1.38
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res (2013) 1.30
Novel mechanisms of drug resistance in leukemia. Leukemia (2000) 1.27
Exosome removal as a therapeutic adjuvant in cancer. J Transl Med (2012) 1.24
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun (2014) 1.21
The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet (2013) 1.21
The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Res (2011) 1.20
Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol Ther (2013) 1.19
Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One (2014) 1.18
Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol Med (2003) 1.16
Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell (2013) 1.14
MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon). J Biol Chem (2013) 1.13
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med (2013) 1.13
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res (2013) 1.12
Multidrug resistance related molecules in human and murine lung. J Clin Pathol (2002) 1.10
The role of microRNAs in the regulation of cancer stem cells. Front Genet (2014) 1.09
Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells. Proc Natl Acad Sci U S A (2014) 1.08
MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis. J Clin Invest (2014) 1.07
Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. BMC Cancer (2014) 1.07
MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One (2012) 1.06
MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene (2013) 1.05
An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells. Mol Cancer (2011) 1.05
Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment. Eur J Cancer (2013) 1.04
Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. J Clin Invest (2000) 1.04
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy. Mol Ther (2014) 1.03
MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2. Cell Death Dis (2014) 1.02
miR-155 drives telomere fragility in human breast cancer by targeting TRF1. Cancer Res (2014) 1.02
Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β. Sci Rep (2013) 1.00
MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Cancer Lett (2013) 0.99
The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis. Genes Dev (2013) 0.98
Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography. Anal Biochem (1979) 0.97
Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac J Clin Oncol (2012) 0.97
Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69. Br J Cancer (1989) 0.95
MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1. Biochem Biophys Res Commun (2014) 0.93
Functional significance of macrophage-derived exosomes in inflammation and pain. Pain (2014) 0.92
Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. Mol Ther (2013) 0.91
MDR1 gene expression in primary colorectal carcinomas. Br J Cancer (1993) 0.89
Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells (2014) 0.87